Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing.

Molfetta R, Milito ND, Zitti B, Lecce M, Fionda C, Cippitelli M, Santoni A, Paolini R.

Eur J Immunol. 2019 Jun;49(6):873-883. doi: 10.1002/eji.201847848. Epub 2019 Mar 27.

PMID:
30888046
2.

A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis.

Gallais Sérézal I, Hoffer E, Ignatov B, Martini E, Zitti B, Ehrström M, Eidsmo L.

J Allergy Clin Immunol. 2019 Apr;143(4):1444-1454. doi: 10.1016/j.jaci.2018.08.048. Epub 2018 Sep 27.

3.

Natural killer cells in inflammation and autoimmunity.

Zitti B, Bryceson YT.

Cytokine Growth Factor Rev. 2018 Aug;42:37-46. doi: 10.1016/j.cytogfr.2018.08.001. Epub 2018 Aug 10. Review.

PMID:
30122459
4.

NCR+ ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice.

Mikami Y, Scarno G, Zitti B, Shih HY, Kanno Y, Santoni A, O'Shea JJ, Sciumè G.

Eur J Immunol. 2018 Jul;48(7):1174-1180. doi: 10.1002/eji.201847480. Epub 2018 Apr 16.

5.

Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cells.

Villarino AV, Sciumè G, Davis FP, Iwata S, Zitti B, Robinson GW, Hennighausen L, Kanno Y, O'Shea JJ.

J Exp Med. 2017 Oct 2;214(10):2999-3014. doi: 10.1084/jem.20150907. Epub 2017 Sep 15.

6.

Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells.

Zitti B, Molfetta R, Fionda C, Quatrini L, Stabile H, Lecce M, de Turris V, Ricciardi MR, Petrucci MT, Cippitelli M, Gismondi A, Santoni A, Paolini R.

Sci Rep. 2017 Sep 5;7(1):10445. doi: 10.1038/s41598-017-10403-0.

7.

Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay.

Abruzzese MP, Bilotta MT, Fionda C, Zingoni A, Soriani A, Vulpis E, Borrelli C, Zitti B, Petrucci MT, Ricciardi MR, Molfetta R, Paolini R, Santoni A, Cippitelli M.

J Hematol Oncol. 2016 Dec 1;9(1):134.

8.

Regulation of NKG2D Expression and Signaling by Endocytosis.

Molfetta R, Quatrini L, Zitti B, Capuano C, Galandrini R, Santoni A, Paolini R.

Trends Immunol. 2016 Nov;37(11):790-802. doi: 10.1016/j.it.2016.08.015. Epub 2016 Sep 22. Review.

PMID:
27667711
9.

Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.

Quatrini L, Molfetta R, Zitti B, Peruzzi G, Fionda C, Capuano C, Galandrini R, Cippitelli M, Santoni A, Paolini R.

Sci Signal. 2015 Oct 27;8(400):ra108. doi: 10.1126/scisignal.aab2724.

PMID:
26508790
10.

Regulation of fc receptor endocytic trafficking by ubiquitination.

Molfetta R, Quatrini L, Gasparrini F, Zitti B, Santoni A, Paolini R.

Front Immunol. 2014 Sep 18;5:449. doi: 10.3389/fimmu.2014.00449. eCollection 2014. Review.

11.

c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.

Molfetta R, Quatrini L, Capuano C, Gasparrini F, Zitti B, Zingoni A, Galandrini R, Santoni A, Paolini R.

Eur J Immunol. 2014 Sep;44(9):2761-70. doi: 10.1002/eji.201444512. Epub 2014 Jun 17.

Supplemental Content

Support Center